Dipna Pharmachem Ltd.

BSE: 543594

Dipna Pharmachem Live Share Price Today, Share Analysis and Chart

Name: Dipna Pharmachem Ltd.: Is Infosys Ltd. worth buying?
Item: Dipna Pharmachem Ltd.
Rating: 1.50575
Author: Trendlyne DVM scores

aboutDipna Pharmachem Ltd. (DPL) is an Ahmedabad-based company primarily engaged in the trading and distribution of a wide range of pharmaceutical raw materials, including active pharmaceutical ingredients (APIs), excipients, and specialty chemicals. The ... Read More

0.38(10.00%)

New 52W Low in past week

66,000

BSE Volume

BSE 03 Nov, 2026 2:33 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Dipna Pharmachem is on 04 Nov 2026 for the purpose of Quarterly Results See details

- / 100

27.7 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

8Positive10Negative

44.4%Pass in checklist

045

100

Check P/E Buy Sell Zone

Strong Buy Zone

3.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Dipna Pharmachem Stock Price Analysis

Day Price Range 10.0% 1 Day return	4.2 (LTP) 44.2 LowHigh
Week Price Range 7.5% 1 Week return	4.2 (LTP) 3.64.2 LowHigh
Month Price Range 0.7% 1 Month return	4.2 (LTP) 3.64.5 LowHigh
52 Week Price Range -78.7% 1 Year return	4.2 (LTP) 3.619.9 LowHigh

View full Price History/Seasonality

Competitors/Peers

Revenue Mix

Quarterly

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Dipna Pharmachem annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Dipna Pharmachem Mar-2026 Annual Revenue is Rs 129 Cr which is growth of 3.3% YoY.
POSITIVE
Annual Net Profit Dipna Pharmachem Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of 170.2% YoY.

Dipna Pharmachem Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	8.9%	33%	129.1	124.9	164.3	99.9	72.8	31	30.6	20.2	16.6	9.6	9.8
TotalOperatingRevenues_A Operating Rev. Ann.	8.9%	33%	129.1	124.9	164.3	99.9	72.8	31	30.5	20.2	16.6	9.6	9.7
OI_A Other Income Ann.	-	-	0	0		0	0	0	0	0	0	0	0.1
OEXPNS_A Operating Exp. Ann.	8.3%	32.3%	124.1	121.5	160.9	97.6	70.5	30.6	30.2	19.7	16.2	9.3	9.5
OEXPNS_A Operating Exp. Ann.	8.3%	32.3%	124.1	121.5	160.9	97.6	70.5	30.6	30.2	19.7	16.2	9.3	9.5
OP_A Operating Profit Ann.	29.5%	65.7%	5	3.4	3.4	2.3	2.2	0.4	0.3	0.5	0.4	0.3	0.3
OPMPCT_A OPM Ann. %	18.3%	24.6%	3.87%	2.75%	2.09%	2.34%	3.08%	1.29%	1.02%	2.40%	2.32%	3.09%	2.87%
TotalExpenses_A Total Exp. Ann. ⌄	8.4%	32.3%	125.6	123.5	162.9	98.6	71.2	31	30.5	20.1	16.5	9.6	9.7
OtherExpenses_A Other Exp. Ann.	112%	93.3%	16.2	7.3	2.6	1.7	1.3	0.6	0.9	0.6	0.6	0.2	0.2
EmployeeBenefitExpenses_A Employee Exp. Ann.	0%	0%	0.4	0.4	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.2	0.2
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	27.7%	65.7%	5	3.5	3.4	2.4	2.3	0.4	0.3	0.5	0.4	0.3	0.3
EBIDTPCT_A EBITDA Ann. margin %	18.3%	23.8%	3.89%	2.76%	2.09%	2.35%	3.10%	1.34%	1.06%	2.43%	2.41%	3.18%	3.41%
INT_A Interest Ann.	14.5%	30.3%	1.5	2	2	1	0.7	0.4	0.3	0.4	0.3	0.3	0.3
DEP_A Depr.	-	-	0	0	0	0	0	0	0	0
PBT_A PBT Ann.	35.7%	103.6%	3.5	1.4	1.4	1.4	1.6	0.1	0.1	0.1	0.1	0	0.1
TAX_A Tax Ann.	21.6%	-	0.9	0.5	0.3	0.5	0.4	0		0	0	0	0
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	42.4%	-	2.6	1	1.1	0.9	1.2	0	0.1	0	0.1	0	0
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	42.4%	-	2.6	1	1.1	0.9	1.2	0	0.1	0	0.1	0	0
NETPCT_A NPM Ann. %	30.7%	96.1%	2.03%	0.77%	0.66%	0.91%	1.60%	0.07%	0.19%	0.15%	0.34%	0.25%	0.38%
EPS_adj_A EPS Adj. latest Ann.	35.7%	-	1	0.4	0.4	0.4	0.4	0	0	0	0	0	0
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

3.4%

2Y CAGR

-11.4%

3Y CAGR

8.9%

5Y CAGR

33%

7Y CAGR

30.3%

10Y CAGR

29.4%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

160%

2Y CAGR

53.7%

3Y CAGR

42.4%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

2.1%

2Y CAGR

-12.2%

3Y CAGR

8.3%

5Y CAGR

32.3%

7Y CAGR

30.1%

10Y CAGR

29.3%

Operating Expenses Annual Cr growth is lower than historical averages.

Dipna Pharmachem Technical Analysis

Dipna Pharmachem EMA & SMA

Bullish+2

5 bullish, 3 bearish

Bullish5

Bearish3

5 Day	3.8
10 Day	3.9
12 Day	3.9
20 Day	4.0

26 Day	4.1
50 Day	4.5
100 Day	5.6
200 Day	8

Dipna Pharmachem Delivery And Volume

Daily Avg. Delivery Volume %

02 Nov, 2026100.0%

Week86.1%

Month89.9%

Dipna Pharmachem Active Candlesticks

Hikkake Uptrend

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Dipna Pharmachem Resistance and Support

3.81

Pivot

First Resistance	3.8
Second Resistance	3.9
Third Resistance	3.9

First Support	3.8
Second Support	3.8
Third Support	3.8

Day RSI	38.1
Day MACD	-0.2
Day MFI	33
Day MACD Signal Line	-0.2

Dipna Pharmachem Beta

1 Month	-0.6
1 Year	0.7

3 Month	-0.5
3 Year	0.2

Dipna Pharmachem Price Change Analysis

↑0.7%

Over 1 Month

LowHigh

3.64.5

↓-6.9%

Over 3 Months

LowHigh

3.67.2

↓-47.4%

Over 6 Months

LowHigh

3.68.7

↓-78.7%

Over 1 Year

LowHigh

3.619.9

Dipna Pharmachem Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Keyur Dipakkumar Shah	Promoter	2,397,000	9.1 %
Kajal Ashok Jain	Public	1,124,000	4.3 %

HISTORICAL PROMOTER HOLDING

Promoters holding remains unchanged at 9.13% in Sep 2026 qtr

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Dipna Pharmachem Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
HRIDAY AATISH SHAH	Bulk	Purchase	14 Aug 2026	5.70	150,000	BSE
NEERITA SANJAY JAIN	Bulk	Sell	04 Aug 2026	4.10	297,000	BSE
SANJAY NIRMAL JAIN HUF	Bulk	Sell	04 Aug 2026	4.39	273,000	BSE
NAMITA HEMANT JAIN	Bulk	Sell	27 Jul 2026	4.25	177,000	BSE
NAMITA HEMANT JAIN	Bulk	Sell	07 Jul 2026	5.55	156,000	BSE
HEMANT NARESH JAIN HUF	Bulk	Sell	01 Jul 2026	5.89	132,000	BSE
HEMANT NARESH JAIN HUF	Bulk	Sell	26 May 2026	7.22	144,000	BSE
NAMITA HEMANT JAIN	Bulk	Purchase	21 Nov 2025	16.86	240,000	BSE
KALPALABDHI SECURITIES PRIVATE LIMITED	Bulk	Sell	21 Nov 2025	16.89	237,000	BSE
KALPALABDHI SECURITIES PRIVATE LIMITED	Bulk	Sell	20 Nov 2025	15.51	324,000	BSE

All deals

All insider trades

Dipna Pharmachem Corporate Actions

Dipna Pharmachem Board Meetings

Dipna Pharmachem past and upcoming board meetings.

#Ex-Date	Purpose	Notes
104 Nov 2026	Quarterly Results	-
202 Jul 2026	Audited Results	(Revised)
326 Nov 2025	Half Yearly Results	(Revised)
407 Jul 2025	Audited Results	-
512 Mar 2025	Issue Of Warrants & Others	Inter-alia, to consider 1. The draft Valuation Report for issue of Convertible warrants on preferential basis. 2. The Notice convening Extra- Ordinary General Meeting.. 3. Other business matters.

Dipna Pharmachem Rights issue

Dipna Pharmachem rights issue history, along with record, ex-rights dates, and rights ratios.

#Ex-Date	Ratio	Face Value	Premium	Record Date
112 Dec 2024	13.0:12.0	10	-	12 Feb 2024

All Corporate Actions

Dipna Pharmachem Corporate Filings

Dipna Pharmachem BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Date	Announcement Title	Details	Links
31 Oct 2026	Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 4Th November, 2026	Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 4th November, 2026 at 5:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055 inter alia, to consider and discuss: 1. The Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2026 along with Limited Review Report. 2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting.	PDF
24 Oct 2026	Dipna Pharmachem Ltd - 543594 - Announcement under Regulation 30 (LODR)-Resignation of Director	Announcement under Regulation 30 (LODR) - Resignation of Director	PDF
24 Oct 2026	Dipna Pharmachem Ltd - 543594 - Announcement under Regulation 30 (LODR)-Change in Directorate	Announcement under Regulation 30 (LODR) - Change in Directorate	PDF
23 Oct 2026	Dipna Pharmachem Ltd - 543594 - Appointment of Company Secretary and Compliance Officer	Appointment of Company Secretary and Compliance Officer	PDF
23 Oct 2026	Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015	Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015	PDF

VIEW ALL

Dipna Pharmachem DocumentsAsk MarketMind AI

Dipna Pharmachem Annual Reports

Dipna Pharmachem financials, including annual results, balance sheets, and cash flow statements.

Date	Report Title	Links
2025	Annual Report Mar-2025	Link
2024	Annual Report Mar-2024	Link
2023	Annual Report Mar-2023	Link

Dipna Pharmachem - Company Profile

Dipna Pharmachem Management Structure

Dipna Pharmachem management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF	HISTORY & DETAILS
Keyur Shah	Managing Director,Chief Financial Officer	-	Mar 25

Dipna Pharmachem Board of Directors

Dipna Pharmachem Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Keyur Shah	Managing Director & CFO	-	Mar 25
Dipna Shah	Non Executive Director	-	Mar 25
Nandish Jani	Independent Director	-	Mar 25
Parin Bhavsar	Independent Non Exe. Director	-	Mar 25

About

Website: www.dipnapharmachem.com

About the company - Business Profile

Dipna Pharmachem Ltd. (DPL) is an Ahmedabad-based company primarily engaged in the trading and distribution of a wide range of pharmaceutical raw materials, including active pharmaceutical ingredients (APIs), excipients, and specialty chemicals. The company acts as a crucial intermediary in the pharmaceutical supply chain, catering to various formulation manufacturers. DPL's business model is focused on sourcing quality products and ensuring timely delivery to its diverse client base across India.

Key Points

Key Facts:
- Founded: Incorporated in 2011.
- Headquarters: Ahmedabad, Gujarat, India.
- Products: Active Pharmaceutical Ingredients (APIs), excipients, and specialty chemicals.
- Stock Listing: Listed on the BSE (Bombay Stock Exchange).
Operations and Resources:
- The company operates primarily through its corporate office in Ahmedabad.
- Its operations are centered on a trading model where it manages logistics and supply chain distribution for chemical and pharmaceutical products.
Market and Significance:
- DPL serves the pharmaceutical and chemical industries, playing a strategic role in sourcing materials for domestic formulation companies.
- The company leverages its network to provide cost-effective sourcing solutions to its customers.
Business Model:
- DPL operates on a trading-centric business model. It excels in supply chain management, procurement, and distribution of chemical products.
- Its strengths lie in maintaining a diverse product portfolio and established relationships with both suppliers and customers.
Revenue Breakdown (FY2025):
- Revenue from Operations: ₹14,669.08 Lakhs (H1 FY2024-25, noting that the company often reports half-yearly and annual numbers).
- Geographical Breakdown: Primarily domestic (India), with ongoing efforts to expand its reach.
Key Products and Services:
- APIs: Provides essential raw materials for drug manufacturing.
- Excipients: Distributes substances used as a medium for drugs.
- Chemical Trading: Involved in the trade of various industrial chemicals.
Employee Information:
- As of recent filings, the company maintains a lean organizational structure typical of trading entities, focusing on procurement and sales expertise.
Strategic Initiatives and Outlook:
- DPL is focused on diversifying its product range to include more high-margin specialty chemicals.
- The company aims to enhance its digital procurement systems to improve operational efficiency and response times.
- Future outlook remains tied to the growth of the Indian pharmaceutical sector and the company's ability to navigate price volatility in the chemical markets.

References

Results Nov 2025

Dipna Pharmachem FAQ

Dipna Pharmachem today is trading in the green, up by 10% at ₹4.18.

Dipna Pharmachem is currently trading up 10% on an intraday basis. In the past week the stock rose 7.46%. Stock has been down 6.9% in the past quarter and fell 78.71% in the past year. You can view this in the share price history/seasonality section.

Dipna Pharmachem is listed on BSE with ticker 543594. It's currently trading on BSE at a share price of ₹4.18.

The market cap of Dipna Pharmachem is ₹10.99 Cr. as of Nov 03, 2026.

Dipna Pharmachem has never announced any dividend since the time of its listing on the BSE exchange.

Dipna Pharmachem has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

Dipna Pharmachem reported ₹2.05 Cr. in revenue, ₹0.18 Cr. in net profit, and ₹0.46 Cr. in EBITD as of Jul 02, 2026 for Q4 FY25-26.

There are no analyst predictions for stock price target for Dipna Pharmachem.

The PE ratio of Dipna Pharmachem is 4.18 as of Nov 03, 2026.

The PB ratio of Dipna Pharmachem is 0.26 as of Nov 03, 2026.

There are no analyst reports for Dipna Pharmachem.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Dipna Pharmachem Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Dipna Pharmachem Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Dipna Pharmachem - Annual

Dipna Pharmachem annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Dipna Pharmachem Mar-2026 Annual Revenue is Rs 129 Cr which is growth of 3.3% YoY.

Annual Net Profit Dipna Pharmachem Mar-2026 Annual Net Profit is Rs 3 Cr which is growth of 170.2% YoY.

Dipna Pharmachem Technical Analysis

Dipna Pharmachem EMA & SMA

Dipna Pharmachem Delivery And Volume

Dipna Pharmachem Active Candlesticks

Dipna Pharmachem Resistance and Support

Dipna Pharmachem Beta

Dipna Pharmachem Price Change Analysis

Dipna Pharmachem Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Dipna Pharmachem Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Dipna Pharmachem Corporate Actions

Dipna Pharmachem Board Meetings

Dipna Pharmachem past and upcoming board meetings.

Dipna Pharmachem Rights issue

Dipna Pharmachem rights issue history, along with record, ex-rights dates, and rights ratios.

Dipna Pharmachem Corporate Filings

Dipna Pharmachem BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Dipna Pharmachem DocumentsAsk MarketMind AI

Dipna Pharmachem Annual Reports

Dipna Pharmachem financials, including annual results, balance sheets, and cash flow statements.

Dipna Pharmachem - Company Profile

Dipna Pharmachem Management Structure

Dipna Pharmachem management structure with salaries, total experience, and qualifications.

Dipna Pharmachem Board of Directors

Dipna Pharmachem Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Key Points

Dipna Pharmachem FAQ

How is Dipna Pharmachem today?

Dipna Pharmachem today is trading in the green, up by 10% at ₹4.18.

How has Dipna Pharmachem performed historically?

Dipna Pharmachem is currently trading up 10% on an intraday basis. In the past week the stock rose 7.46%. Stock has been down 6.9% in the past quarter and fell 78.71% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Dipna Pharmachem on NSE and BSE exchanges?

Dipna Pharmachem is listed on BSE with ticker 543594. It's currently trading on BSE at a share price of ₹4.18.

What is the market cap of Dipna Pharmachem?

The market cap of Dipna Pharmachem is ₹10.99 Cr. as of Nov 03, 2026.

When did Dipna Pharmachem last pay a dividend, and what has its dividend history been?

Dipna Pharmachem has never announced any dividend since the time of its listing on the BSE exchange.

Has Dipna Pharmachem issued any bonus shares or share splits recently?

Dipna Pharmachem has never issued stock splits or bonus shares since the time of its listing on the BSE exchange.

What do the financial statements and annual reports of Dipna Pharmachem Indicate?

Dipna Pharmachem reported ₹2.05 Cr. in revenue, ₹0.18 Cr. in net profit, and ₹0.46 Cr. in EBITD as of Jul 02, 2026 for Q4 FY25-26.

What is the target share price of Dipna Pharmachem according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Dipna Pharmachem.

What is the PE Ratio of Dipna Pharmachem?

The PE ratio of Dipna Pharmachem is 4.18 as of Nov 03, 2026.

What is the PB Ratio of Dipna Pharmachem?

The PB ratio of Dipna Pharmachem is 0.26 as of Nov 03, 2026.

Where can I check the latest Research Reports about Dipna Pharmachem?

There are no analyst reports for Dipna Pharmachem.

How can I be notified of real time alerts about Dipna Pharmachem stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.